A Phase 1 interventional study of Olatorepatide in adults living with overweight or obesity without diabetes

Study Description

A clinical study testing a new injectable weight loss medication called Olatorepatide to evaluate its safety, tolerability, and effectiveness in adults who are overweight or obese but do not have diabetes

Study Details

Registry ID:

NCT07685808

Conditions:

Overweight or Obesity

Phase:

Phase 2

Target Enrollment:

360 participants

Start Date:

July 28, 2026

Age Range:

18–999 years

Healthy Volunteers:

No

Study Locations (25 sites)

• Chase Medical Research
  Waterbury, ConnecticutUnited States, United States
• AGA Clinical Trials
  Hialeah, FloridaUnited States, United States
• Alliance for Multispecialty Research (AMR) Clinical Miami
  Doral, FloridaUnited States, United States
• AMR Clinical - Miami
  Doral, FloridaUnited States, United States
• NYC Research Inc
  New York, New YorkUnited States, United States
• AMR Clinical - Fort Myers
  Fort Myers, FloridaUnited States, United States
• Clinical Site Partners, LLC DBA Flourish Research
  Winter Park, FloridaUnited States, United States
• K2 Medical Research Maitland LLC, Main Office
  Maitland, FloridaUnited States, United States
• Charter Research LLC - The Villages
  The Villages, FloridaUnited States, United States
• Flourish Research, Jacksonville Center for Clinical Research
  Jacksonville, FloridaUnited States, United States
• IMA Clinical Research St. Petersburg
  St. Petersburg, FloridaUnited States, United States
• The IMA Group, IMA Clinical Research St. Petersburg
  St. Petersburg, FloridaUnited States, United States
• Flourish Research, Nature Coast Clinical Research
  Inverness, FloridaUnited States, United States
• Rochester Clinical Research
  Rochester, New YorkUnited States, United States
• Tribe Clinical Research
  Greenville, South CarolinaUnited States, United States
• AMR Clinical - Lexington
  Lexington, KentuckyUnited States, United States
• AMR Clinical - Mobile
  Mobile, AlabamaUnited States, United States
• Flourish Research, Ravenswood Rheumatology
  Chicago, IllinoisUnited States, United States
• Charter Research LLC - Chicago
  Chicago, IllinoisUnited States, United States
• Flourish Research - Chicago
  Chicago, IllinoisUnited States, United States
• AMR Clinical - Chicago Oak Brook
  Oak Brook, IllinoisUnited States, United States
• AMR Clinical - Wichita
  Wichita, KansasUnited States, United States
• AMR Clinical Wichita
  Wichita, KansasUnited States, United States
• Velocity Clinical Research - Omaha
  Omaha, NebraskaUnited States, United States
• Diablo Clinical Research - Flourish Research
  Walnut Creek, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →